首页> 外文OA文献 >Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of VEGFR2 and MET in osteosarcoma

【2h】

Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of VEGFR2 and MET in osteosarcoma

机译：anlotinib，一种新型的小分子酪氨酸激酶抑制剂，通过双封闭的VEGFR2抑制生长和转移，并在骨肉瘤中满足

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Gangyang Wang; Mengxiong Sun; Yafei Jiang; Tao Zhang; Wei Sun; Hongsheng Wang; Fei Yin; Zhuoying Wang; Weilin Sang; Jing Xu; Min Mao; Dongqing Zuo; Zifei Zhou; Chongren Wang; Zeze Fu; Zongyi Wang; Zhenfeng Duan; Yingqi Hua; Zhengdong Cai;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via via dual blockade of VEGFR2 and MET in osteosarcoma [J] . Wang Gangyang, Sun Mengxiong, Jiang Yafei, International Journal of Cancer =: Journal International du Cancer . 2019,第4期

机译：anlotinib，一种新型的小分子酪氨酸激酶抑制剂，通过双封闭的VEGFR2抑制生长和转移，并在骨肉瘤中满足
2. Cabozantinib Suppresses Tumor Growth and Metastasis in Hepatocellular Carcinoma by a Dual Blockade of VEGFR2 and MET (vol 20, pg 2959, 2014) [J] . Xiang Q., Chen W., Ren M., Clinical cancer research: an official journal of the American Association for Cancer Research . 2016,第9期

机译：卡波替尼通过VEGFR2和MET的双重阻断抑制肝细胞癌的肿瘤生长和转移（第20卷，第2959页，2014年）
3. Cabozantinib suppresses tumor growth and metastasis in hepatocellular carcinoma by a dual blockade of VEGFR2 and MET. [J] . Qingfeng Xiang, Weiqiang Chen, Meng Ren, Clinical cancer research: an official journal of the American Association for Cancer Research . 2014,第11期

机译：卡波替尼通过VEGFR2和MET的双重阻滞抑制肝细胞癌的肿瘤生长和转移。
4. The Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 (Iressa) Suppresses Proliferation and Invasion of Human Oral Squamous Carcinoma Cells via p53 Independent and MMP, uPAR Dependent Mechanism [C] . EUN JU LEE, JIN HA WHANG, NAM KYEONG JEON, Meeting on Cell Signaling World: Signal Transduction Pathways as Therapeutic Targets . 2007

机译：表皮生长因子受体酪氨酸激酶抑制剂ZD1839（Iressa）通过独立于p53和MMP，uPAR依赖性机制抑制人口腔鳞状细胞癌细胞的增殖和侵袭
5. Analysis of pp60c-src and pp62c-yes intracellular protein tyrosine kinase function in colon tumor cell growth regulation using herbimycin A, a tyrosine kinase specific inhibitor. [D] . Garcia, Roy. 1995

机译：使用酪氨酸激酶特异性抑制剂除草霉素A分析pp60c-src和pp62c-yes细胞内蛋白酪氨酸激酶在结肠肿瘤细胞生长调节中的功能。
6. The dual blockade of MET and VEGFR2 signaling demonstrates pronounced inhibition on tumor growth and metastasis of hepatocellular carcinoma [O] . Yu Zhang, Xiaomei Gao, Ying Zhu, 2018

机译：MET和VEGFR2信号的双重阻断表明对肝细胞癌的肿瘤生长和转移有明显的抑制作用
7. The selective epidermal growth factor receptor tyrosine kinase inhibitor PD153035 suppresses expression of prometastasis phenotypes in malignant pleural mesothelioma cells in vitro [O] . Cole George W., Alleva Annette M., Reddy Rishindra M., 2005

机译：选择性表皮生长因子受体酪氨酸激酶抑制剂PD153035体外抑制恶性胸膜间皮瘤细胞前转移表型的表达
8. Novel Screen for Suppressors of Breast Tumor Cell Growth Using an Oriented Random Peptide Library Method to Identify Inhibitors of the ErbB2 Tyrosine Kinase [R] . Carraway, K. 2000

机译：使用定向随机肽库方法鉴定ErbB2酪氨酸激酶抑制剂的新型乳腺肿瘤细胞生长抑制剂筛选

Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of VEGFR2 and MET in osteosarcoma

著录项

相似文献

相关主题

期刊订阅